Mutual Fund Details

SBI Healthcare Opportunities Fund Direct Plan-IDCW

Name: SBI Healthcare Opportunities Fund Direct Plan-IDCW
Brand: SBI Mutual Fund

Equity Pharma

NAV

₹332.2181

as on 02 May 2025, 09:00 PM

₹-1.2519(0.38%)

Last Change

Scheme Ratings

rated by Value Research

Pharma

Rankings based on | as on Invalid date

Schemes Managed By

Tanmaya Desai

Fund Manager

Download the Paytm Money app now!

Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.

Zero brokerage for 30 days
Zero account opening fees
Zero AMC for life

Scan QR code to download the app

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,91,212

₹1,97,399

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹97,399

Profit (absolute return)

97.40%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Start investing in minutes

Download app to Explore

Scan this QR code to download the app now!

Or download from

Investment Returns

In the last 3 months

1.79%

In the last 6 months

0.74%

In the last 1 year

22.19%

In the last 3 years

97.40%

In the last 5 years

216.86%

In the last 10 years

250.79%

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

SBI Healthcare Opportunities Fund Direct Plan-IDCW

as of 31 Mar 2025, 12:00 AM

₹3,610.51 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.50% if redeemed within 15 days

0.90%

Expense Ratio

Plan

Dividend

2.99%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 0.50% if redeemed within 15 days

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Mar 2025

Sort By

Value

Sector

Healthcare

93.71%

₹3,383.40 Cr

Chemicals

3.22%

₹116.26 Cr

Others

3.07%

₹110.84 Cr

Sectors Holding in this Mutual Fund

as on 31 Mar 2025

Sort By

Value

Sector

Healthcare

93.71%

₹3,383.40 Cr

Chemicals

3.22%

₹116.26 Cr

Others

3.07%

₹110.84 Cr

Companies Holding in this Mutual Fund

as on 31 Mar 2025

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

13.78%

₹497.53 Cr

Max Healthcare Institute Ltd.

7.67%

₹276.93 Cr

Divi's Laboratories Ltd.

6.66%

₹240.46 Cr

Cipla Ltd.

6.65%

₹240.10 Cr

Lonza Group Ag

4.94%

₹178.36 Cr

Others

60.30%

₹2,177.13 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Mar 2025

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

13.78%

₹497.53 Cr

Max Healthcare Institute Ltd.

7.67%

₹276.93 Cr

Divi's Laboratories Ltd.

6.66%

₹240.46 Cr

Cipla Ltd.

6.65%

₹240.10 Cr

Lonza Group Ag

4.94%

₹178.36 Cr

Others

60.30%

₹2,177.13 Cr

View All

Funds in this Category

This fund's returns:

25.42%

Return Duration

3 Years

SBI Healthcare Opportunities Fund Direct Plan-Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About SBI Healthcare Opportunities Fund Direct Plan-IDCW

SBI Healthcare Opportunities Fund Direct Plan-IDCW is a Equity mutual fund scheme from SBI Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Tanmaya Desai. It has an AUM of ₹3,610.51 Crores and the latest NAV decalared is ₹332.218 as on 04 May 2025 at 1:09 pm.

SBI Healthcare Opportunities Fund Direct Plan-IDCW scheme return performance in last 1 year is 22.19%, in last 3 years is 97.40% and 691.22% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.